Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary
3.1. Market Snippet by Product Type
3.2. Market Snippet by Pathway Type
3.3. Market Snippet by Route of Administration
3.4. Market Snippet by Application
3.5. Market Snippet by Distribution Channel
3.6. Market Snippet by Region

4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing scientific advancements in the treatment for infantile spasm
4.1.1.2. Rising prevalence of infantile spasms
4.1.2. Restraints:
4.1.2.1. High cost of treatment
4.1.3. Opportunity
4.1.4. Impact Analysis

5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. PEST Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Regulatory Analysis
5.6. Reimbursement Analysis
5.7. Unmet Needs

6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Vismodegib*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Glasdegib
7.4. Sonidegib
7.5. Itraconazole
7.6. Oxysterol
7.7. Saridegib

8. By Pathway Type
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathway Type
8.1.2. Market Attractiveness Index, By Pathway Type
8.2. Canonical Hedgehog Signaling*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Non-Canonical Hedgehog Signaling
8.3.1. Smoothened dependent non-Canonical
8.3.2. Smoothened independent non-Canonical

9. By Application
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
9.1.2. Market Attractiveness Index, By Application Segment
9.2. Basal Cell Carcinoma*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Acute Myeloid Leukemia
9.4. Medulloblastoma
9.5. Gorlin Syndrome
9.6. Others

10. By Route of Administration
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration Segment
10.1.2. Market Attractiveness Index, By Route of Administration Segment
10.2. Oral*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
10.3. Topical

11. By Distribution Channel
11.1. Introduction
11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel Segment
11.1.2. Market Attractiveness Index, By Distribution channel Segment
11.2. Retail Pharmacies*
11.2.1. Introduction
11.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
11.3. Hospital Pharmacies
11.4. Online Pharmacies

12. By Region
12.1. Introduction
12.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathway Type
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathway Type
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration Type
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathway Type
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration Type
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathway Type
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration Type
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathway Type
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration Type
12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
13. Competitive Landscape
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Product Benchmarking
13.4. Key Companies to Watch
13.5. Company with disruptive technology
13.6. Start Up Companies
14. Company Profiles
14.1. Sun Pharmaceutical Industries Limited*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Pfizer Inc
14.3. F. Hoffmann-La Roche AG
14.4. Infinity Pharmaceuticals
14.5. Max Biopharma Inc
14.6. PellePharm Inc
14.7. Takeda Pharmaceutical Company Ltd
14.8. Mayne Pharma Group Limited
14.9. Bristol-Myers Squibb Company
14.10. Novartis(*LIST NOT EXHAUSTIVE)
15. DataM Intelligence
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us